There is no other way to protect the body from the epidemic of corona but to create hard immunity through the only vaccine.
The immunization program will prevent coronary heart disease by creating a way for millions of people to achieve hard immunity, and we will be able to return to normal life as soon as we can achieve this.
Therefore, one of the major achievements of the Government of Bangladesh in protecting the people from COVID-19 is the collection of Oxford-AstraZeneca vaccines approved by the World Health Organization and the commencement of mass immunization activities from February 8; Where 130 countries of the world have not yet collected vaccines.
Although the interest in participating in immunization activities is increasing day by day among the people of Bangladesh who are physically weak and suffering from chronic diseases such as cancer, kidney, diabetes, liver (hepatitis), neurological and high blood pressure; They are in a dilemma as to whether they will be able to get vaccinated or whether there will be a problem with getting vaccinated.
However, people with low immunity can become seriously ill with coronavirus infection at any time. People with immunocompromised or immunosuppressed (reduced immunity) or clinically very weak (bedridden) nature have a higher risk of coronary infection, as well as a serious illness, and even death if infected. Immunosuppressants can usually be caused by certain diseases such as AIDS, cancer, diabetes, malnutrition, and certain genetic disorders.
According to the UK's National Health Service, those at risk for coronary heart disease are those with chronic diseases (hypertension, diabetes, heart disease, and stroke, kidney or liver patients with dialysis); Treating cancer with immunotherapy or chemotherapy or radiotherapy or antibody treatment; Organs have been replaced; Patients with blood or bone marrow cancer (e.g. leukemia, lymphoma or myeloma); Who have had a bone marrow or stem cell transplant in the last 6 months; Taking high doses of steroids or immunosuppressants; Severe lung disease (e.g. severe asthma or severe COPD); Pregnant; Problems with the spleen or the spleen has been removed and people 60 or older.
Clinical trials of vaccines for pregnant, breastfeeding mothers, and those under 16 or 18 years of age have not yet been completed, so they are advised not to be vaccinated. However, the UK's Joint Vaccine and Immunization Committee has recommended that Oxford vaccines and other corona vaccines be given to breastfeeding mothers in addition to the live virus vaccine.
No serious allergic reactions were observed during clinical trials of the Pfizer, Mordana, and Oxford vaccines, and none of those with severe allergic problems were included in any of the tests. People with allergies can take the vaccine because the Oxford vaccine does not contain an allergen called polyethylene glycol. The Oxford Ticker Clinical Trial did not show any serious side effects in patients with a heart attack or stroke, as well as in diabetic patients with lung disease, so these patients can take the vaccine.
Some treatments, such as chemotherapy, radiation, stem cell or bone marrow transplantation, and immunotherapy, can affect the immune system, which can also reduce the effectiveness of the vaccine. Even then, the UK's Joint Vaccine and Immunization Committee is advising these people to take the Covid-19 vaccine. There is no risk that corona vaccines may harm immunosuppressed people, but they may not get as much protection from the vaccine. Drugs that can weaken the immune system or treatments that reduce the effectiveness of our immune system, can also reduce the effectiveness of vaccines.
The question may be, why doesn't the vaccine work in the body of immunosuppressed people, including some cancer patients? Effective immunity is needed to build the immune system of vaccines in the human body. Therefore, the human body must be able to function properly to prevent the tick antigen, so that the activation of immune cells, such as B and T cells, can take place and plasma B cell antibodies are produced. Therefore, people with a lack of effective immune cells may be unable to develop a fully-fledged immune system through the Covid-19 vaccine.
According to the American Society of Hematology, when should patients with immunosuppressive therapy be vaccinated? Vaccination is recommended at least 2-4 weeks before planned immunosuppressive therapy and transplant or spenectomy. If a patient is receiving immunosuppressive therapy, the vaccine should be given 6 months after stopping the therapy to increase the chances of developing immunity. Moreover, the vaccine should be given 3-6 months after hematopoietic cell transplantation.
It is important for people at high risk of the corona to get the corona vaccine first with the advice of a doctor to protect themselves from the risk of serious illness or death due to corona. However, care must be taken to ensure that effective protection against corona infection has been developed or not at all, even after vaccination, and that other family members must be vaccinated to protect themselves from the risk of infection. Keep in mind that no vaccine can provide 100% protection and the Oxford vaccine can provide 82-90% protection.
Therefore, even those who are at high risk for corona, even after being vaccinated, should maintain social distance and adhere to hygiene guidelines in accordance with WHO guidelines, including masks.
0 Comments